Copyright
©The Author(s) 2015.
World J Hepatol. Sep 28, 2015; 7(21): 2336-2343
Published online Sep 28, 2015. doi: 10.4254/wjh.v7.i21.2336
Published online Sep 28, 2015. doi: 10.4254/wjh.v7.i21.2336
Class | Baseline SCr within 3 mo, most recent prior to hospital admission | Urinary output |
I | ↑ SCr ≥ 0.3 mg/dL or ↑ SCr 1.5-1.9 times over baseline1 | Not required |
II | ↑ SCr 2.0-2.9 times over baseline1 | Not required |
III | ↑ SCr ≥ 3 times over baseline or if baseline SCr ≥ 4 mg/dL: ↑ SCr ≥ 0.3 mg/dL1 or initiation of renal replacement therapy | Not required |
Progression of AKI | Progression of AKI to a higher stage and/or need for renal replacement therapy | |
Regression of AKI | Regression of AKI to a lower stage | |
No response | No regression of AKI | |
Partial response | Regression of AKI stage with a reduction of SCr to ≥ 0.3 mg/dL above the baseline value | |
Full response | Return of SCr to a value within 0.3 mg/dL of the baseline value |
- Citation: Bittencourt PL, Farias AQ, Terra C. Renal failure in cirrhosis: Emerging concepts. World J Hepatol 2015; 7(21): 2336-2343
- URL: https://www.wjgnet.com/1948-5182/full/v7/i21/2336.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i21.2336